Press Release Archive - 2014

This section contains information and press releases about us. This information should be considered accurate only as of the date prepared. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Antares Pharma, Inc. is not obligated to update the press releases and information contained in this section of the Company’s website.

06 Jan 2014

Antares Pharma to Present at the 32nd Annual JP Morgan Healthcare Conference
READ  

15 Jan 2014

Antares Pharma Announces Availability of OTREXUP (METHOTREXATE) Injection for Subcutaneous use to Treat RA and Psoriasis in Adults and Polyarticular Idiopathic Arthritis in Children
READ  

19 Feb 2014

Antares Pharma to Participate in the 2014 RBC Capital Markets' Global Healthcare Conference
READ  

20 Feb 2014

Antares Pharma Announces Positive Results From the Vibex Quickshot Pharmacokinetic Study in Testosterone Deficient Men
READ  

06 Mar 2014

Antares Pharma to Host Fourth Quarter 2013 Operating and Financial Results Conference Call
READ  

10 Mar 2014

Antares Pharma Announces LEO Pharma's Launch of OTREXUP (Methotrexate) Injection to Dermatologists for Adults with Psoriasis
READ  

12 Mar 2014

Antares Pharma Receives Second Milestone Payment from LEO Pharma in OTREXUP Collaboration
READ  

13 Mar 2014

Antares Pharma Reports Fourth Quarter and Full Year 2013 Operating and Financial Results
READ  

16 Apr 2014

Antares Pharma Announces Additional Patent Coverage for OTREXUP
READ  

17 Apr 2014

Drug-Exposure Limitations of Oral Methotrexate at Doses Greater than or Equal to 15 MG May be overcome with subcutaneous administration
READ  

24 Apr 2014

Antares Pharma to Present at the Deutsche Bank Securities Inc. 39th Annual Healthcare Conference
READ  

06 May 2014

Antares Pharma Announces Update to Quickshot Testosterone Program
READ  

09 May 2014

Antares Pharma Reports First Quarter 2014 Operating and Financial Results
READ  

07 May 2014

Antares Pharma to Present at the Bank of America Merrill Lynch 2014 Healthcare Conference
READ  

20 May 2014

Antares Pharma Announces the Publication of Three Abstracts at the 2014 European League Against Rheumatism Annual Congress
READ  

22 May 2014

Antares Pharma Appoints Jennifer Evans Stacey ESQ., Senior Vice President , General Counsel, Human Resources and Secretary
READ  

28 May 2014

Antares Pharma to Present at the Jefferies 2014 Global Healthcare Conference
READ  

24 Jun 2014

Antares Pharma Announces Change in Senior Leadership
READ  

25 Jun 2014

Rapid Restoration and Consistent Maintenance of Steady Blood Levels Achieved With Once-Weekly Subcutaneous Administration of Testosterone Delivered With a Novel Auto Injector
READ  

22 Jul 2014

Antares Pharma Annouces First Patient Dosed In Phase 3 QuickShot® Study Evaluating Testosterone-Deficient Adult Males
READ  

31 Jul 2014

Antares Pharma to Host Second Quarter 2014 Operating and Financial Results Conference Call
READ  

03 Sep 2014

Antares Pharma to Present at the Morgan Stanley Healthcare Conference
READ  

15 Sep 2014

Antares Pharma Announces Promotion of Robert F. Apple to Chief Operating Officer
READ  

05 Aug 2014

Antares Pharma Reports Second Quarter 2014 Operating and Financial Results
READ  

30 Oct 2014

Antares Pharma to Host Third Quarter 2014 Operating and Financial Results Conference Call
READ  

03 Nov 2014

Antares Pharma Announces Last Patient Enrolled in Phase 3 Quickshot Study Evaluating Testosterone-Deficient Adult Males
READ  

06 Nov 2014

Antares Pharma Reports Third Quarter 2014 Operating and Financial Results
READ  

18 Nov 2014

Antares Pharma Appoints James E. Fickenscher, Senior Vice President, Chief Financial Officer
READ  

25 Nov 2014

Antares Pharma to Present at the 26th Annual Piper Jaffray Healthcare Conference
READ  

03 Dec 2014

Antares Pharma to Present at the 25th Annual Oppenheimer Healthcare Conference
READ